Drug copayment coupons to reduce patient cost-sharing have become nearly ubiquitous for high-priced brand … equilibrium price effects of coupons, we employ individual-level data to estimate a discrete choice model of demand for multiple … sclerosis drugs. We use our demand estimates to parameterize a model of drug price negotiations. For this category of drugs, we …

We analyze the effects on consumers of an extreme policy experiment -- Napsterizing' pharmaceuticals -- whereby all … associated with greater access to the current stock of pharmaceuticals, future consumers will be harmed by reducing the flow of … new pharmaceuticals to the market. Our estimates of the consumer surpluses at stake are based on the stylized facts …

suggest that misinformation and related consumer mistakes explain a sizable share of the brand premium for health products …

agencies and private organizations all conducting investigations into the pricing patterns for generic drugs. Price spikes for … selected old, off-patent drugs have also been widely reported in the media. To place these generic price increases into context …, we construct two chained Laspeyres consumer price indexes (CPIs), using the 2007-2016 IBM MarketScan Commercial Claims …

of broadcast and non-broadcast DTCA on price and demand, utilizing an extended time series of monthly records for all … models suggest that broadcast DTCA positively impacts own-sales and price, with an estimated elasticity of 0.10 and 0 ….04 respectively. Relative to broadcast DTCA, non-broadcast DTCA has a smaller impact on sales (elasticity of 0.05) and price …

Generic utilization rates have risen substantially since the enactment of The Drug Price Competition and Patent Term … erosion of brand sales at patent expiration is heavily discounted due to the long time horizon to generic erosion when an R …

This paper examines the relationship between drug price and drug quality and how it varies across two of the most … standards and price control mechanisms (MES+PC). Through a simple model of adverse selection we model the interaction between … greater incentives to produce high quality drugs. Second, an MES+PC mix reduces the difference in price between the highest …

region. This paper evaluates the effect of this program on the price and utilization of pharmaceutical treatments … potentially negotiate price discounts through their ability to influence the market share of specific treatments. Using data on … the average price and increased the total utilization of prescription drugs by Medicare recipients. Our results further …